1. Home
  2. RICK vs CHRS Comparison

RICK vs CHRS Comparison

Compare RICK & CHRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo RCI Hospitality Holdings Inc.

RICK

RCI Hospitality Holdings Inc.

N/A

Current Price

$31.25

Market Cap

214.6M

ML Signal

N/A

Logo Coherus BioSciences Inc.

CHRS

Coherus BioSciences Inc.

N/A

Current Price

$1.32

Market Cap

177.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RICK
CHRS
Founded
1983
2010
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
214.6M
177.7M
IPO Year
1996
2014

Fundamental Metrics

Financial Performance
Metric
RICK
CHRS
Price
$31.25
$1.32
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$5.51
AVG Volume (30 Days)
41.0K
945.2K
Earning Date
05-08-2026
05-07-2026
Dividend Yield
1.11%
N/A
EPS Growth
N/A
472.00
EPS
0.16
N/A
Revenue
$144,896,000.00
N/A
Revenue This Year
$19.32
$73.08
Revenue Next Year
N/A
$30.94
P/E Ratio
$193.38
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.76
$1.06
52 Week High
$38.00
$2.62

Technical Indicators

Market Signals
Indicator
RICK
CHRS
Relative Strength Index (RSI) 72.79 47.84
Support Level $24.45 $1.15
Resistance Level N/A $1.48
Average True Range (ATR) 1.21 0.11
MACD 0.52 0.00
Stochastic Oscillator 84.86 46.84

Price Performance

Historical Comparison
RICK
CHRS

About RICK RCI Hospitality Holdings Inc.

RCI Hospitality Holdings Inc through its subsidiaries, owns and operates establishments that offer live adult entertainment, restaurant, and or bar operations. It also owns and operates a communication company serving the adult nightclub industry. The company's operating business segments are Nightclubs, Bombshells, and Others. It operates nightclubs through the following brands Rick's Cabaret, Vivid Cabaret, Tootsie's Cabaret, Club Onyx, and Jaguars Club. In the Bombshells segment, the company is building a chain of Restaurants and Sports Bars in Dallas, Austin, and Houston, Texas. It derives the majority of revenue from the Nightclubs segment that engages in the sale of alcoholic beverages, food, and merchandise items; service in the form of cover charges, and room rentals.

About CHRS Coherus BioSciences Inc.

Coherus Oncology Inc is a fully integrated commercial-stage inventive oncology company with an approved next-generation PD-1 inhibitor, LOQTORZI, and a pipeline that includes two mid-stage clinical candidates targeting liver, lung, head & neck, and other cancers. Its portfolio includes LOQTORZI which was developed for its ability to block PD-1 interactions with its ligands, PD-L1 and PD-L2, by binding to the FG loop on the PD-1 receptor. Company believe blocking PD-1 interactions with PD-L1 and PD-L2 can help to promote the immune systems.

Share on Social Networks: